✨ 26 results found - Searched 21206 records in 4ms.
Tesis
Efektivitas Bevacizumab sebagai kemoterapi paliatif kanker kolorektal stadium lanjut pada protokol XELOX dan protokol mFOLFOX6
2017 | BY Mangema Junias R.S - Agi Satria Putranto- Effectiveness of Bevacizumab as palliative chemotherapy for late-stage colorectal cancer on XELOX protocol and mFOLFOX6 protocol.
- Nomor Panggil T17163fk
Tesis
Kajian Farmakoekonomi Kemoterapi Rejimen Berbasis Platinum Dengan Dua Jenis Obat (Platinum-Based Doublet) Pada Pasien Adenokarsinoma Paru Mutasi Epidermal Growth Factor Receptor Negatif Di RS Persahabatan
2019 | BY Rianyta - Vivian Soetikno - Melva Louisa - Elisna Syahruddin- Pharmacoeconomic Study of Platinum-Based Doublet Chemotherapy Regimens in Patients with Lung Adenocarcinoma Negative Epidermal Growth Factor Receptor Mutations at Persahabatan Hospital.
- Nomor Panggil T19319fk
Tesis
Kesintasan Pasien Kanker Payudara yang Mendapat Kemoterapi Berbasis Antrasiklin di Rumah Sakit Umum Daerah Kotamadya Bogor : Peran Kelengkapan Imunohistokimia dan Imaging
2019 | BY Marthino Robinson - Tubagus Djumhana Atmakusuma - Cosphiadi Irawan - Hamzah Shatri- The Survival of Breast Cancer Patients That Get Anthracyclin–Based Chemotherapy in RSUD Kotamadya Bogor : The Role of Immunohistochemistry and Imaging.
- Nomor Panggil T19253fk
Tesis
Hitung Jenis Leukosit sebagai Prediktor Neutropenia Akut Awitan Pertama Pascakemoterapi R-CHOP pada Pasien Diffuse Large B-cell Lymphoma
2019 | BY Griskalia Christine - Lugyanti Sukrisman - Noorwati Sutandyo - Cleopas Martin Rumende- Differential Count of Leukocytes as A Predictor of The First Onset Acute Neutropenia After R-CHOP Chemotherapy in Diffuse Large B-cell Lymphoma Patients.
- Nomor Panggil T19185fk
Tesis
Pengaruh Penambahan Mannitol pada Hidrasi terhadap Kejadian Acute Kidney Injury Pasca Kemoterapi Berbasis Cisplatin Dosis Tinggi
2018 | BY Syahidatul Wafa - Andhika Rachman - Pringgodigdo Nugroho - Sukamto Koesnoe- The Effect of Mannitol Addition to Hydration towards Acute Kidney Injury Event after High Dose Cisplatin Chemotherapy.
- Nomor Panggil T18233fk
Tesis
Perbandingan Efikasi Dan Toksisitas Hematologi Kemoterapi Lini I Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Jenis Karsinoma Sel Skuamosa (KSS) Dengan Adenokarsinoma EGFR wild typeDi RSUP Persahabatan
2018 | BY Enita Mayasari - Elisna Syahruddin - Andika Chandra Putra- The Efficacy and Hematological Toxicity of First-line Chemotherapy of Non-small Cell Lung Cancer (NSCLC) Patients Treated at Persahabatan Hospital Jakarta, Indonesia .
- Nomor Panggil T18483fk
Tesis
Hasil dari pemberian Bleomycin, Etoposide, dan Cisplatin, rejimen : kemoterapi pada pasien germ cell tumor metastasis sebagai kemoterapi : lini pertama di Rumah Sakit Pusat Kanker Nasional Dharmais tahun : 2011-2017
2018 | BY Adianty Khadijah - Rahmat Budi Susanto - Harahap, Edward U.- Outcome of Bleomycin, Etoposide, and Cisplatin, chemotherapy : regimen in metastatic germ cell tumors patients as first-line : chemotherapy in Dharmais National Cancer Hospital year 2011-2017.
- Nomor Panggil T18440fk
Tesis
Kesesuaian Terapi Antibiotik Empiris dengan Kuman Patogen dan Pengaruhnya terhadap Keberhasilan Terapi pada Pasien Demam Neutropenia Pasca Kemoterapi di Rumah Sakit Cipto Mangunkusumo Periode 2015-2018
2018 | BY Muhadi - Stephanie Chandra - Lie Khie Chen - Ikhwan Rinal- The Appropriateness of Empirical Antibiotic Therapy with Pathogen and Its Effect toward Successful Therapy in Chemo-related Febrile Neutropenic patients at Cipto Mangunkusumo Hospital From 2015-2018.
- Nomor Panggil T18192fk
Tesis
Perubahan indeks massa tubuh, persentase otot rangka dan kadar albumin pada pasien kanker paru karsinoma bukan sel kecil ( KPKBSK ) sebelum dan setelah kemoterapi
2014 | BY Yenni Sari Siregar - Elisna Syahruddin - Wahju Aniwidyaningsih- Body mass index ( BMI), percentage of scletal muscle and albumin in non small cell lung cancer ( NSCLC) patiens before and after chemotherapy.
- Nomor Panggil T14583fk
Tesis
Angka tahan hidup pasien kangker paru kelompok bukan sel kecil non skuamosa yang mendapat terapi target Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor dan yang mendapat Kemoterapi lini pertama di Rumah sakit Persahabatan
2014 | BY Sita Laksmi Andarini - Kasum Supriadi - Achmad Hudoyo- The survival rate of nonsquamous by non small cell lung carcinoma patiens who are given by target therapy epidermal growth facttor receptor-tyrosin kinase inhibitors and those given by first-line kemotheraphy treatment at Persahabatan hospital.
- Nomor Panggil T14579fk